0001209191-14-042349.txt : 20140625 0001209191-14-042349.hdr.sgml : 20140625 20140618163604 ACCESSION NUMBER: 0001209191-14-042349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140616 FILED AS OF DATE: 20140618 DATE AS OF CHANGE: 20140618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 14928431 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-06-16 1 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS, 9TH FLOOR NEW YORK NY 10036 0 0 1 0 Common Stock, $0.001 par value 2014-06-16 4 S 0 400751 7.57 D 10287553 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2014-06-16 4 S 0 100000 7.85 D 10187553 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2014-06-16 4 S 0 150000 7.81 D 10037553 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2014-06-16 4 S 0 944400 7.71 D 9093153 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2014-06-16 4 S 0 224400 7.79 D 8868753 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. On June 16, 2014, Quintessence Fund L.P. sold 157,999 shares of Common Stock, QVT Fund IV LP sold 240,000 shares of Common Stock and QVT Fund V LP sold 1,421,552 shares of Common Stock. As a result, Quintessence Fund L.P. directly beneficially owns 770,125 shares of Common Stock, QVT Fund IV LP directly beneficially owns 1,169,793 shares of Common Stock and QVT Fund V LP directly beneficially owns 6,928,835 shares of Common Stock. QVT Associates GP LLC is the general partner of QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. (together with QVT Fund IV LP, and QVT Fund V LP, the "Funds"). QVT Financial LP is the investment manager for the Funds and therefore may be deemed the beneficial owner of the Common Stock held by the Funds. QVT Financial GP LLC is the general partner of QVT Financial LP and therefore may be deemed the beneficial owner of Common Stock beneficially owned by QVT Financial LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. /s/ Tracy Fu, Managing Member 2014-06-18